UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Cardiovascular effects of Atomoxetine in children, adolescents, and adults

Drug safety, 2003-01, Vol.26 (10), p.729-740

2003

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Pain (Amsterdam), 2005-12, Vol.119 (1-3), p.5

2005

Link zum Volltext

Verfügbarkeit prüfen

A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic Pain

Pain medicine (Malden, Mass.), 2005-09, Vol.6 (5), p.346-356

2005

Link zum Volltext

Verfügbarkeit prüfen

Seizure risk in patients with attention‐deficit‐hyperactivity disorder treated with atomoxetine

Developmental medicine and child neurology, 2007-07, Vol.49 (7), p.498-502

2007

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions

Journal of diabetes and its complications, 2009-09, Vol.23 (5), p.349-359

2009

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials

Journal of women's health (Larchmont, N.Y. 2002), 2007-10, Vol.16 (8), p.1145

2007

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

Drug safety, 2008-01, Vol.31 (4), p.345-354

2008

Link zum Volltext

Verfügbarkeit prüfen

INCREASED DIAGNOSES OF GASTROINTESTINAL CANCERS FOLLOWING GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING CLOPIDOGREL OR WARFARIN

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E1042-E1042

2011

Link zum Volltext

Verfügbarkeit prüfen

Safety and adverse event profile of duloxetine

Expert opinion on drug safety, 2005-11, Vol.4 (6), p.987-993

2005

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain

Pain medicine (Malden, Mass.), 2007-09, Vol.8 (6), p.503-513

2007

Link zum Volltext

Verfügbarkeit prüfen

QT Correction Methods in Children and Adolescents

Journal of cardiovascular electrophysiology, 2005-01, Vol.16 (1), p.76-80

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety and side effect profile of fluoxetine

Expert opinion on drug safety, 2004-09, Vol.3 (5), p.495-504

Wernicke, Joachim F

2004

Link zum Volltext

Verfügbarkeit prüfen

Detecting treatment emergent adverse events in clinical trials : A comparison of spontaneously reported and solicited collection methods

Drug safety, 2005-01, Vol.28 (11), p.1057-1063

2005

Link zum Volltext

Verfügbarkeit prüfen

The placebo response in pain and depression: in search of a common pathway

Frontiers in bioscience (Scholar edition), 2010-01, Vol.2 (1), p.106

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients

Current drug safety, 2009-01, Vol.4 (1), p.22

2009

Link zum Volltext

Verfügbarkeit prüfen

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: A prospective, placebo-controlled assessment

Journal of clinical psychopharmacology, 2004-02, Vol.24 (1), p.30-35

2004

Link zum Volltext

Verfügbarkeit prüfen

Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources

Current drug safety, 2008-05, Vol.3 (2), p.154

2008

Link zum Volltext

Verfügbarkeit prüfen

Answers to the Most Common Questions About the Hepatic Safety Profile of Duloxetine

Postgraduate medicine, 2008-07, Vol.120 (2), p.111-118

2008

Link zum Volltext

Verfügbarkeit prüfen

Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial

Current therapeutic research, 2006-09, Vol.67 (5), p.283-304

2006

Link zum Volltext

Verfügbarkeit prüfen

Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: The absence of an effect related to agitation and suicidal behavior

Depression and anxiety, 1997, Vol.6 (1), p.31-39

1997

Link zum Volltext

Verfügbarkeit prüfen

Effect of Duloxetine in the Management of DPNP: Results from Subgroup Analyses Using Pooled Placebo-Controlled Studies

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A126

2005

Link zum Volltext

Verfügbarkeit prüfen

Low-threshold AlGaN-based UVB VCSELs enabled by post-growth cavity detuning

Applied physics letters, 2022-09, Vol.121 (10)

2022

Link zum Volltext

Verfügbarkeit prüfen

Improvement in Visceral Adipose Tissue and LDL Cholesterol by High PUFA Intake: 1-Year Results of the NutriAct Trial

Nutrients, 2024-04, Vol.16 (7), p.1057

2024

Link zum Volltext

Verfügbarkeit prüfen

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

Pediatrics (Evanston), 2001-11, Vol.108 (5), p.E83

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial

The American journal of clinical nutrition, 2023-04, Vol.117 (4), p.785-793

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Female
(15)
Male
(14)
Adolescent
(10)
Adult
(10)
Child
(10)
Duloxetine Hydrochloride
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Double-Blind Method
(8)
Duloxetine
(8)
Pharmacology & Pharmacy
(8)
Pharmacology. Drug Treatments
(8)
Atomoxetine Hydrochloride
(7)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(7)
Middle Aged
(7)
Serotonin Uptake Inhibitors - Adverse Effects
(7)
Thiophenes - Adverse Effects
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cardiovascular effects of Atomoxetine in children, adolescents, and adults

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic Pain

Seizure risk in patients with attention‐deficit‐hyperactivity disorder treated with atomoxetine

Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions

Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials

Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder

INCREASED DIAGNOSES OF GASTROINTESTINAL CANCERS FOLLOWING GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING CLOPIDOGREL OR WARFARIN

Safety and adverse event profile of duloxetine

An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain

QT Correction Methods in Children and Adolescents

Safety and side effect profile of fluoxetine

Detecting treatment emergent adverse events in clinical trials : A comparison of spontaneously reported and solicited collection methods

The placebo response in pain and depression: in search of a common pathway

Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: A prospective, placebo-controlled assessment

Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources

Answers to the Most Common Questions About the Hepatic Safety Profile of Duloxetine

Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial

Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: The absence of an effect related to agitation and suicidal behavior

Effect of Duloxetine in the Management of DPNP: Results from Subgroup Analyses Using Pooled Placebo-Controlled Studies

Low-threshold AlGaN-based UVB VCSELs enabled by post-growth cavity detuning

Improvement in Visceral Adipose Tissue and LDL Cholesterol by High PUFA Intake: 1-Year Results of the NutriAct Trial

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial

Suchergebnisse filtern